Trial intelligence / Profile preview

Lidocaine-ketorolac versus lidocaine-dexmedetomidine for intravenous regional anesthesia

IRCT2014090614056N3Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in pain comparing Lidocaine + ketorolac with Lidocaine + dexmedetomidine (2 arms). Primary endpoint: Analgesic effect. Started Dec 2013; status: completed.

02

Drugs

lidocaineketorolacdexmedetomidine
03

Conditions

pain

Beyond the preview

Go deeper on IRCT2014090614056N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014090614056N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call